Lista de obras -

A hypermethylated phenotype is a better predictor of survival than MGMT methylation in anaplastic oligodendroglial brain tumors: a report from EORTC study 26951.

artículo científico publicado en 2011

A new sensitive PCR assay for one-step detection of 12 IDH1/2 mutations in glioma

artículo científico publicado en 2014

A phase I study of LY317615 (enzastaurin) and temozolomide in patients with gliomas (EORTC trial 26054).

artículo científico publicado en 2012

ASPM-associated stem cell proliferation is involved in malignant progression of gliomas and constitutes an attractive therapeutic target

artículo científico publicado en 2010

Actionable FGFR1 and BRAF mutations in adult circumscribed gliomas

artículo científico publicado en 2019

Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment [...]

artículo científico publicado en 2006

An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patients

artículo científico publicado en 2010

Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile

artículo científico publicado en 2008

Association of matrix metalloproteinase 2 plasma level with response and survival in patients treated with bevacizumab for recurrent high-grade glioma

artículo científico publicado en 2014

COLD PCR HRM: a highly sensitive detection method for IDH1 mutations ⬇️

artículo científico publicado el 9 de noviembre de 2010

Chromosome 7p11.2 (EGFR) variation influences glioma risk

scientific journal article

Chromosome 9p and 10q losses predict unfavorable outcome in low-grade gliomas

artículo científico publicado en 2009

Comparative assessment of 5 methods (methylation-specific polymerase chain reaction, MethyLight, pyrosequencing, methylation-sensitive high-resolution melting, and immunohistochemistry) to analyze O6-methylguanine-DNA-methyltranferase in a series of

artículo científico publicado en 2012

DGKI methylation status modulates the prognostic value of MGMT in glioblastoma patients treated with combined radio-chemotherapy with temozolomide

artículo científico publicado en 2014

Detection, Characterization, and Inhibition of FGFR-TACC Fusions in IDH Wild-type Glioma.

artículo científico publicado en 2015

Expression of follicle-stimulating hormone receptor by the vascular endothelium in tumor metastases ⬇️

artículo científico publicado el 20 de mayo de 2013

FABP7 expression in glioblastomas: relation to prognosis, invasion and EGFR status

artículo científico publicado en 2007

Genetic risk profiles identify different molecular etiologies for glioma

artículo científico publicado en 2010

Genome-wide association study identifies multiple susceptibility loci for glioma ⬇️

artículo científico publicado en 2015

Genome-wide association study of glioma and meta-analysis

artículo científico publicado en 2012

Genomic aberrations associated with outcome in anaplastic oligodendroglial tumors treated within the EORTC phase III trial 26951

artículo científico publicado en 2010

Genomic changes in progression of low-grade gliomas

artículo científico publicado en 2008

Gliomatosis cerebri: a review

artículo científico publicado en 2014

IDH mutations: genotype-phenotype correlation and prognostic impact.

artículo científico publicado en 2014

IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group

artículo científico publicado en 2010

IDH1(R132H) mutation increases U87 glioma cell sensitivity to radiation therapy in hypoxia

artículo científico publicado en 2014

Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33

artículo científico publicado en 2014

Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study

artículo científico publicado en 2010

KIAA1549‐BRAFFusions and IDH Mutations Can Coexist in Diffuse Gliomas of Adults ⬇️

artículo científico publicado el 18 de junio de 2012

Leptomeningeal Spread in Glioblastoma: Diagnostic and Therapeutic Challenges

scientific article published on 31 August 2020

Leptomeningeal metastases from solid malignancy: a review

artículo científico publicado en 2005

MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951.

artículo científico publicado en 2009

Methylation profiling identifies 2 groups of gliomas according to their tumorigenesis

artículo científico publicado en 2010

Molecular changes in gliomas

artículo científico publicado en 2004

Multi-omics analysis of primary glioblastoma cell lines shows recapitulation of pivotal molecular features of parental tumors.

artículo científico publicado en 2016

NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype

artículo científico publicado en 2010

NOTCH2 is neither rearranged nor mutated in t(1;19) positive oligodendrogliomas

artículo científico publicado en 2009

Oligodendrogliomas: An update on basic and clinical research ⬇️

artículo científico publicado el 1 de mayo de 2003

Palliative care in patients with primary brain tumors

artículo científico publicado en 2004

Pattern of care of high-grade gliomas

artículo científico publicado en 2006

Peri-ictal pseudoprogression in patients with brain tumor

artículo científico publicado en 2011

Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastoma

artículo científico publicado en 2006

Prognostic stratification of patients with anaplastic gliomas according to genetic profile

artículo científico publicado en 2006

Prognostic value of health-related quality-of-life data in predicting survival in patients with anaplastic oligodendrogliomas, from a phase III EORTC brain cancer group study

artículo científico publicado en 2007

Quantifying the heritability of glioma using genome-wide complex trait analysis

artículo científico publicado en 2015

Response assessment in recurrent glioblastoma treated with irinotecan-bevacizumab: comparative analysis of the Macdonald, RECIST, RANO, and RECIST + F criteria

artículo científico publicado en 2012

Search for new loci and low-frequency variants influencing glioma risk by exome-array analysis ⬇️

artículo científico publicado en 2016

Silencing erythropoietin receptor on glioma cells reinforces efficacy of temozolomide and X-rays through senescence and mitotic catastrophe

artículo científico publicado en 2015

TCF12 is mutated in anaplastic oligodendroglioma

artículo científico publicado en 2015

The oculopharyngeal muscular dystrophy locus maps to the region of the cardiac alpha and beta myosin heavy chain genes on chromosome 14q11.2-q13

artículo científico publicado en 1995

The renal v‐ATPase a4 subunit is expressed in specific subtypes of human gliomas ⬇️

artículo científico publicado el 27 de marzo de 2012

Tumor and endothelial cell hybrids participate in glioblastoma vasculature

artículo científico publicado en 2014

Lista de obras de

A hypermethylated phenotype is a better predictor of survival than MGMT methylation in anaplastic oligodendroglial brain tumors: a report from EORTC study 26951.

A new sensitive PCR assay for one-step detection of 12 IDH1/2 mutations in glioma

A phase I study of LY317615 (enzastaurin) and temozolomide in patients with gliomas (EORTC trial 26054).

ASPM-associated stem cell proliferation is involved in malignant progression of gliomas and constitutes an attractive therapeutic target

Actionable FGFR1 and BRAF mutations in adult circumscribed gliomas

Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment [...]

An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patients

Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile

Association of matrix metalloproteinase 2 plasma level with response and survival in patients treated with bevacizumab for recurrent high-grade glioma

COLD PCR HRM: a highly sensitive detection method for IDH1 mutations ⬇️

Chromosome 7p11.2 (EGFR) variation influences glioma risk

Chromosome 9p and 10q losses predict unfavorable outcome in low-grade gliomas

Comparative assessment of 5 methods (methylation-specific polymerase chain reaction, MethyLight, pyrosequencing, methylation-sensitive high-resolution melting, and immunohistochemistry) to analyze O6-methylguanine-DNA-methyltranferase in a series of

DGKI methylation status modulates the prognostic value of MGMT in glioblastoma patients treated with combined radio-chemotherapy with temozolomide

Detection, Characterization, and Inhibition of FGFR-TACC Fusions in IDH Wild-type Glioma.

Expression of follicle-stimulating hormone receptor by the vascular endothelium in tumor metastases ⬇️

FABP7 expression in glioblastomas: relation to prognosis, invasion and EGFR status

Genetic risk profiles identify different molecular etiologies for glioma

Genome-wide association study identifies multiple susceptibility loci for glioma ⬇️

Genome-wide association study of glioma and meta-analysis

Genomic aberrations associated with outcome in anaplastic oligodendroglial tumors treated within the EORTC phase III trial 26951

Genomic changes in progression of low-grade gliomas

Gliomatosis cerebri: a review

IDH mutations: genotype-phenotype correlation and prognostic impact.

IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group

IDH1(R132H) mutation increases U87 glioma cell sensitivity to radiation therapy in hypoxia

Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33

Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study

KIAA1549‐BRAFFusions and IDH Mutations Can Coexist in Diffuse Gliomas of Adults ⬇️

Leptomeningeal Spread in Glioblastoma: Diagnostic and Therapeutic Challenges

Leptomeningeal metastases from solid malignancy: a review

MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951.

Methylation profiling identifies 2 groups of gliomas according to their tumorigenesis

Molecular changes in gliomas

Multi-omics analysis of primary glioblastoma cell lines shows recapitulation of pivotal molecular features of parental tumors.

NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype

NOTCH2 is neither rearranged nor mutated in t(1;19) positive oligodendrogliomas

Oligodendrogliomas: An update on basic and clinical research ⬇️

Palliative care in patients with primary brain tumors

Pattern of care of high-grade gliomas

Peri-ictal pseudoprogression in patients with brain tumor

Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastoma

Prognostic stratification of patients with anaplastic gliomas according to genetic profile

Prognostic value of health-related quality-of-life data in predicting survival in patients with anaplastic oligodendrogliomas, from a phase III EORTC brain cancer group study

Quantifying the heritability of glioma using genome-wide complex trait analysis

Response assessment in recurrent glioblastoma treated with irinotecan-bevacizumab: comparative analysis of the Macdonald, RECIST, RANO, and RECIST + F criteria

Search for new loci and low-frequency variants influencing glioma risk by exome-array analysis ⬇️

Silencing erythropoietin receptor on glioma cells reinforces efficacy of temozolomide and X-rays through senescence and mitotic catastrophe

TCF12 is mutated in anaplastic oligodendroglioma

The oculopharyngeal muscular dystrophy locus maps to the region of the cardiac alpha and beta myosin heavy chain genes on chromosome 14q11.2-q13

The renal v‐ATPase a4 subunit is expressed in specific subtypes of human gliomas ⬇️

Tumor and endothelial cell hybrids participate in glioblastoma vasculature